Menu Search
Equities

PZ Cormay SA

CRM:WSE

PZ Cormay SA

Actions
Health CareMedical Equipment and Services
  • Price (PLN)0.48
  • Today's Change0.00 / 0.00%
  • Shares traded13.37k
  • 1 Year change-16.96%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in PLNIncome statement in PLNView more

Year on year PZ Cormay SA had revenues fall -3.67% from 85.36m to 82.23m, though the company grew net income from a loss of 6.96m to a smaller loss of 4.50m.
Gross margin38.24%
Net profit margin-9.32%
Operating margin-7.82%
Return on assets-8.39%
Return on equity-13.84%
Return on investment-12.80%
More ▼

Cash flow in PLNView more

In 2023, PZ Cormay SA increased its cash reserves by 196.52%, or 2.54m. Cash Flow from Investing totalled 5.52m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 3.25m for operations while cash used for financing totalled 19.00k.
Cash flow per share-0.0314
Price/Cash flow per share--
Book value per share0.6109
Tangible book value per share0.3534
More ▼

Balance sheet in PLNView more

PZ Cormay SA has a Debt to Total Capital ratio of 8.75%, a higher figure than the previous year's 4.80%.
Current ratio1.38
Quick ratio0.8062
Total debt/total equity0.0966
Total debt/total capital0.0875
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.